Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
12 Février 2025 - 3:03AM
Edgar (US Regulatory)
Exhibit 99.1
CUSIP No. 079174108
JOINT FILING STATEMENT
PURSUANT TO RULE 13D-1(K)(1)
The undersigned hereby consent and agree to the
joint filing of Schedule 13G under the Securities Exchange Act of 1934, as amended, with respect to the Common Stock of Bellevue Life
Sciences Acquisition Corp. together with any or all amendments thereto, when and if required. The parties hereto further consent and agree
to file this Joint Filing Statement pursuant to Rule13d-1(k)(1)(iii) as an exhibit to Schedule 13G, thereby incorporating the same into
such Schedule 13G.
This Joint Filing Statement may be terminated
by any of the undersigned upon written notice or such lesser period of notice as the undersigned may mutually agree.
Dated: February 11, 2025
| |
Bellevue Global Life Science Investors, LLC |
| |
|
| |
By: Bellevue Capital Management LLC, Its Manager |
| |
|
| |
By: |
/s/ Kuk Hyoun Hwang |
| |
|
Kuk Hyoun Hwang, Managing Member of Bellevue Capital Management LLC |
| |
|
|
| |
BCM Europe Ag |
| |
|
| |
By: |
/s/ Kuk Hyoun Hwang |
| |
|
Kuk Hyoun Hwang, Managing Member |
| |
|
|
| |
Bellevue Capital Management LLC |
| |
|
| |
By: |
/s/ Kuk Hyoun Hwang |
| |
|
Kuk Hyoun Hwang, Managing Member |
| |
|
| |
Kuk Hyoun Hwang |
| |
|
| |
/s/ Kuk Hyoun Hwang |
| |
Kuk Hyoun Hwang |
Bellevue Life Sciences A... (NASDAQ:BLACW)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Bellevue Life Sciences A... (NASDAQ:BLACW)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025
